Tanaka et al. reported that metformin suppressed the expression of miR-221 in human pancreatic cancer cells, leading to G1-phase arrest via the upregulation of p27Kip1 [47]. The gene discussed is CDKN1B; the disease is familial pancreatic carcinoma.